​

Funding Round

Series A - Alzheon

Series A - Alzheon

Investment Firm

Overview

Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.

Announced Date

Apr 08, 2015

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Ally Bridge Group

Ally Bridge Group

Ally Bridge Group is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

2

Investor Name
Participant InvestorScott H. Cohen
Participant InvestorAlly Bridge Group

Round Details and Background

Alzheon raised $10000000 on 2015-04-08 in Series A

Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.

Company Funding History

11

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 26, 2016
Debt Financing - Alzheon
-3.1M
Jul 27, 2015
Debt Financing - Alzheon
-6.9M
Apr 08, 2015
Series A - Alzheon
2-10.0M
Jan 09, 2015
Venture Round - Alzheon
-3.0M

Recent Activity

There is no recent news or activity for this profile.